Handelsbanken Fonder’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-63,235
| Closed | -$11.6M | – | 1705 |
|
|
2021
Q2 | $11.6M | Buy |
63,235
+11,918
| +23% | +$2.19M | 0.06% | 300 |
|
|
2021
Q1 | $7.85M | Buy |
51,317
+1,153
| +2% | +$176K | 0.04% | 339 |
|
|
2020
Q4 | $7.84M | Hold |
50,164
| – | – | 0.05% | 325 |
|
|
2020
Q3 | $5.74M | Hold |
50,164
| – | – | 0.04% | 347 |
|
|
2020
Q2 | $5.63M | Sell |
50,164
-9,836
| -16% | -$1.1M | 0.05% | 315 |
|
|
2020
Q1 | $5.39M | Buy |
+60,000
| New | +$5.39M | 0.12% | 143 |
|
|
2019
Q4 | – | Sell |
-81,746
| Closed | -$8.01M | – | 192 |
|
|
2019
Q3 | $8.01M | Sell |
81,746
-14,750
| -15% | -$1.44M | 0.16% | 133 |
|
|
2019
Q2 | $12.6M | Buy |
96,496
+20,000
| +26% | +$2.62M | 0.23% | 112 |
|
|
2019
Q1 | $10.3M | Buy |
76,496
+16,000
| +26% | +$2.16M | 0.2% | 121 |
|
|
2018
Q4 | $5.89M | Sell |
60,496
-6,704
| -10% | -$653K | 0.12% | 141 |
|
|
2018
Q3 | $9.34M | Buy |
67,200
+21,000
| +45% | +$2.92M | 0.18% | 130 |
|
|
2018
Q2 | $5.74M | Sell |
46,200
-5,000
| -10% | -$621K | 0.11% | 142 |
|
|
2018
Q1 | $5.71M | Buy |
51,200
+3,500
| +7% | +$390K | 0.11% | 144 |
|
|
2017
Q4 | $5.7M | Buy |
47,700
+300
| +0.6% | +$35.9K | 0.13% | 131 |
|
|
2017
Q3 | $6.65M | Buy |
47,400
+3,000
| +7% | +$421K | 0.15% | 121 |
|
|
2017
Q2 | $5.4M | Buy |
44,400
+4,000
| +10% | +$487K | 0.14% | 128 |
|
|
2017
Q1 | $4.9M | Buy |
40,400
+4,000
| +11% | +$485K | 0.14% | 119 |
|
|
2016
Q4 | $4.45M | Sell |
36,400
-3,000
| -8% | -$367K | 0.14% | 113 |
|
|
2016
Q3 | $4.83M | Buy |
39,400
+10,665
| +37% | +$1.31M | 0.14% | 121 |
|
|
2016
Q2 | $3.36M | Buy |
28,735
+4,000
| +16% | +$467K | 0.14% | 107 |
|
|
2016
Q1 | $3.44M | Sell |
24,735
-54,332
| -69% | -$7.56M | 0.15% | 109 |
|
|
2015
Q4 | $15.1M | Buy |
+79,067
| New | +$15.1M | 0.29% | 104 |
|